This study reports on our ongoing investigation on hybrid EM-2 analogues, in which the great potential of beta-amino acids was exploited to generate multiple conformational modifications at the key positions 3 and 4 of the parent peptide. The effect on the opioid binding affinity was evaluated, by means of ligand stimulated binding assays, which indicated a high nanomolar affinity toward the mu-receptor, with appreciable mu/delta selectivity, for some of the new compounds. The three-dimensional properties of the high affinity mu opioid receptor (MOR) ligands were investigated by proton nuclear magnetic resonance, molecular dynamics, and docking studies. In solution, the structures showed extended conformations, which are in agreement with the commonly accepted pharmacophore model for EM-2. From docking studies on an active form of the MOR model, different ligand-receptor interactions have been identified, thus confirming the ability of active compounds to assume a biologically active conformation.

Structural and biological exploration of Phe3-Phe4-modified endomorphin-2 peptidomimetics

BALBONI, GIANFRANCO;
2013

Abstract

This study reports on our ongoing investigation on hybrid EM-2 analogues, in which the great potential of beta-amino acids was exploited to generate multiple conformational modifications at the key positions 3 and 4 of the parent peptide. The effect on the opioid binding affinity was evaluated, by means of ligand stimulated binding assays, which indicated a high nanomolar affinity toward the mu-receptor, with appreciable mu/delta selectivity, for some of the new compounds. The three-dimensional properties of the high affinity mu opioid receptor (MOR) ligands were investigated by proton nuclear magnetic resonance, molecular dynamics, and docking studies. In solution, the structures showed extended conformations, which are in agreement with the commonly accepted pharmacophore model for EM-2. From docking studies on an active form of the MOR model, different ligand-receptor interactions have been identified, thus confirming the ability of active compounds to assume a biologically active conformation.
Peptidomimetics; Opioid receptors; Beta-amino acids; Conformational analysis; Docking studies
File in questo prodotto:
File Dimensione Formato  
ACS Med Chem Lett.pdf

Solo gestori archivio

Tipologia: versione editoriale
Dimensione 724.93 kB
Formato Adobe PDF
724.93 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11584/53919
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 10
social impact